Pharmaceuticals & Biotechnology

BIOVIE INC. CEO pay

Cuong Do, Chief Executive Officer and President. Fiscal year 2026, as reported to the SEC.

Total compensation

$1.4M

$1,389,990 for fiscal 2026: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-09-28SEC accession number 0001520138-26-000395

In context

The median chief executive among 465 Pharmaceuticals & Biotechnology companies was paid $2.2M. The middle half ranged from $1M to $4.9M.

Cuong Do's total is below that median.

See how your pay compares to BIOVIE INC.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: BIOVIE INC.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2026. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.